However, we believe that galectin 3 and LPA may also promote the expression of CD36 in NPC hepatocytes through the PPAR-γ pathway, contributing to lysosome dysfunction probably by analogous mechanisms observed in obesity. The gene discussed is CD36; the disease is obesity disorder.